Alps Advisors Inc Spring Works Therapeutics, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$36.5 - $52.5 $391,097 - $562,537	10,715 Added 25.92%	52,048 $2.56 Million
Q4 2023 Feb 14, 2024	SELL	$18.94 - $37.24 $92,370 - $181,619	-4,877 Reduced 10.55%	41,333 $1.51 Million
Q3 2023 Nov 14, 2023	BUY	$23.12 - $31.38 $5,849 - $7,939	253 Added 0.55%	46,210 $1.07 Million
Q2 2023 Aug 14, 2023	BUY	$23.15 - $32.71 $110,587 - $156,255	4,777 Added 11.6%	45,957 $1.2 Million
Q1 2023 May 10, 2023	SELL	$24.97 - $34.05 $27,641 - $37,693	-1,107 Reduced 2.62%	41,180 $1.06 Million
Q4 2022 Feb 14, 2023	BUY	$21.73 - $28.72 $333,490 - $440,765	15,347 Added 56.97%	42,287 $1.1 Million
Q3 2022 Nov 14, 2022	SELL	$24.1 - $39.66 $57,068 - $93,914	-2,368 Reduced 8.08%	26,940 $769,000
Q2 2022 Aug 11, 2022	SELL	$18.36 - $60.07 $393,032 - $1.29 Million	-21,407 Reduced 42.21%	29,308 $722,000
Q1 2022 May 16, 2022	SELL	$48.97 - $65.46 $307,286 - $410,761	-6,275 Reduced 11.01%	50,715 $2.86 Million
Q4 2021 Feb 09, 2022	SELL	$53.3 - $75.84 $171,839 - $244,508	-3,224 Reduced 5.35%	56,990 $3.53 Million
Q3 2021 Nov 15, 2021	SELL	$62.66 - $88.26 $257,031 - $362,042	-4,102 Reduced 6.38%	60,214 $3.82 Million
Q2 2021 Aug 11, 2021	SELL	$67.45 - $85.63 $1.61 Million - $2.05 Million	-23,915 Reduced 27.1%	64,316 $5.3 Million
Q1 2021 May 07, 2021	BUY	$65.1 - $93.59 $105,136 - $151,147	1,615 Added 1.86%	88,231 $6.49 Million
Q4 2020 Feb 03, 2021	BUY	$48.36 - $77.92 $1.54 Million - $2.47 Million	31,757 Added 57.89%	86,616 $6.28 Million
Q3 2020 Nov 04, 2020	SELL	$36.14 - $51.99 $137,837 - $198,289	-3,814 Reduced 6.5%	54,859 $2.62 Million
Q2 2020 Aug 05, 2020	SELL	$22.98 - $48.57 $448,339 - $947,600	-19,510 Reduced 24.95%	58,673 $2.46 Million
Q1 2020 May 06, 2020	SELL	$20.44 - $41.21 $172,104 - $346,988	-8,420 Reduced 9.72%	78,183 $2.11 Million
Q4 2019 Feb 07, 2020	BUY	$17.74 - $39.52 $1.54 Million - $3.42 Million	86,603 New	86,603 $3.33 Million

Others Institutions Holding SWTX

# of Institutions

238

Shares Held

69.8M

Call Options Held

144K

Put Options Held

257K

Vanguard Group Inc Valley Forge, PA

6.71M
Shares

$262 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.62M
Shares

$219 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

3.84M
Shares

$150 Million
4.54% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.52M
Shares

$137 Million
0.01% of portfolio
Boxer Capital, LLC San Diego, CA

3.42M
Shares

$134 Million
5.82% of portfolio

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.43B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account